Announcement on Making Provisions for Asset Impairment in 2024
Filed with SSE · · 4 pages · Chinese
Harbin Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Harbin Pharmaceutical
- Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
- Announcement on Subsidiary's Drug Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs
- Announcement on Resolution of the 11th Meeting of the 10th Board of Directors
- Clarification Announcement on Media Coverage
- Announcement on Reversals for Asset Impairment
Later from Harbin Pharmaceutical
- Announcement on Attending the Online Collective Reception Day for Investors of Listed Companies in Heilongjiang Jurisdiction in 2025 and the 2024 Annual and Q1 2025 Performance Briefing
- Announcement on Acquisition of Equity by Wholly-owned Subsidiary
- Notice on Convening the 2024 Annual General Meeting
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
Follow Harbin Pharmaceutical into a list and get an email when it puts out news.
Follow Harbin Pharmaceutical